医学蜂蜜在头部和部癌症中使用
Joel Badders1, Orly Coblens2, Viran Ranasinghe2
1School of Medicine, University of Texas Medical Branch, Galveston, USA.
Cureus
|February 26, 2024
概括
医学蜂蜜对头癌 (HNC) 患者有潜在的益处,有助于术后伤口愈合和预防辐射诱导的粘膜炎. 需要进一步的研究来确认其在手术伤口护理中的有效性.
科学领域:
- 在瘤学瘤学.
- 伤口愈合 伤口愈合
- 医学昆虫学 医学昆虫学
背景情况:
- 药用蜂蜜有着悠久的药用历史.
- 在体外研究表明蜂蜜的抗菌和伤口愈合特性.
- 目前在头部和部手术中使用医学蜂蜜是有限的.
研究的目的:
- 审查医用蜂蜜对头癌 (HNC) 患者的有用性.
- 评估医学蜂蜜用于治疗HNC患者的术后伤口.
- 为了评估医学蜂蜜在预防辐射诱导的粘膜炎.
主要方法:
- 欧维德的文学评论,PubMed,和谷歌学者.
- 对摘要进行选,以确定它们是否与医学蜂蜜和HNC相关.
- 对三项关于伤口愈合的随机对照试验 (RCT) 和三项关于粘膜炎的元分析的综述.
主要成果:
- 在术后伤口中使用医学蜂蜜表明住院时间更短,口腔缺陷愈合速度更快.
- 没有观察到对细菌培养或美学结果的显著影响.
- 在HNC患者中,口服蜂蜜的摄入量减少了体重减轻和延迟了严重的辐射诱导性粘膜炎,尽管元分析显示了不同的结果.
结论:
- 有限的证据支持医用蜂蜜用于HNC术后伤口,但存在潜在的益处.
- 需要进行更强大的研究来确认HNC手术伤口愈合的疗效.
- 医学蜂蜜是一种安全的补充疗法,用于预防HNC患者的辐射诱导粘膜炎.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
278
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
278
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163


